Related Experiment Videos
Role of hypertension in coronary artery disease
1Department of Medicine, Brookdale University Hospital and Medical Center, Brooklyn, NY 11212, USA.
Insights
Hypertension management needs to address more than just blood pressure. Focusing on metabolic and vascular factors alongside blood pressure is key to preventing coronary heart disease, the most common hypertension complication.
Area of Science:
- Cardiology
- Vascular Biology
- Hypertension Research
Background:
- Hypertension historically linked to stroke, heart failure, and renal insufficiency.
- Coronary heart disease is now recognized as the most common complication of untreated hypertension.
- Traditional antihypertensive drugs show limited success in reducing coronary events.
Purpose of the Study:
- To explore the multifactorial nature of coronary heart disease in hypertension.
- To propose a "coronary hypothesis" explaining limited treatment efficacy.
- To identify key components contributing to coronary events in hypertensive patients.
Main Methods:
- Review of existing literature on hypertension complications and cardiovascular disease.
- Analysis of the "coronary hypothesis" components: intrinsic vascular activity, risk factors, and hemodynamic factors.
- Consideration of age-related differences in disease progression and treatment implications.
Main Results:
- Hypertension involves a syndrome of metabolic and cardiovascular abnormalities.
- Coronary events result from intrinsic vascular proliferation, concomitant risk factors, and hemodynamic factors.
- Hemodynamic factor treatment benefits elderly patients; younger patients require broader intervention.
Conclusions:
- Effective hypertension management for coronary disease prevention requires a comprehensive approach.
- Addressing intrinsic vascular tendencies, risk factors, and hemodynamics is crucial.
- Tailored treatment strategies considering age and multifactorial contributors are necessary for optimal outcomes.
Abstract:
Historically, stroke, heart failure and renal insufficiency were seen as the major complications of untreated hypertension. More recently, it has become evident that coronary heart disease is probably the most common outcome of this condition. Unlike the other complications of hypertension, coronary events have not been reduced in a meaningful fashion by traditional antihypertensive drug therapy. A partial explanation may lie in the fact that hypertension typically consists of a syndrome of inherited metabolic and cardiovascular abnormalities, and treatment that focuses primarily on blood pressure without taking into account the other factors that contribute to atherosclerotic disease can have only limited protective effects. The coronary hypothesis in hypertension extends this reasoning into 3 separate components. First is an intrinsic tendency to excessive proliferative and hypertrophic activity in vascular tissue, presumably reflecting growth-promoting activity stimulated by increased endocrine and local paracrine effects; second is the impact of the commonly encountered concomitant risk factors, including high blood pressure, that exaggerate and accelerate development of the underlying atherosclerotic lesions; third are hemodynamic factors, including increased variability and sustained elevations of blood pressure, that can destabilize vascular lesions and precipitate acute events. Treatment of these hemodynamic factors in elderly patients, whose underlying vascular changes are already well advanced, is likely to effectively reduce the incidence of vascular endpoints. In younger patients, ongoing vascular proliferative changes and the impact of concomitant risk factors are equally as important as hemodynamic forces in producing coronary disease, and effective treatment must take all these issues into account.